Renewable Energy Certificate (REC) Market worth $45.45 Billion by 2030
Browse in-depth TOC on 'Renewable Energy Certificate (REC) Market'174 - Tables55 - Figures202 - Pages
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=15096856
The solar power, by energy type
RECs, or Renewable Energy Certificates, are all about the environmental benefits of electricity produced from renewable sources like solar, wind, hydro, biomass, and geothermal energy. These certificates are essential for boosting the solar industry, acting as a financial motivator for solar power producers. As the world moves more decisively to cleaner forms of energy, so will RECs take on greater importance in this transition. With RECs, stakeholders can hence move towards a more sustainable future and speed up the use of renewable energy solutions.
1,001-5,000 KWH, by capacity
The Renewable Energy Certificate (REC) Market is witnessing consistent expansion across all capacity segments, fueled by the growing global emphasis on sustainable energy adoption. In this segment, above 5,000 KWh capacity continues to lead, reflecting uptake among industrial and commercial entities. The next growing segment is 1,001-5,000 KWh, since increasing businesses are taking advantage of the capacity while still pursuing their sustainability objectives. The segments having a capacity of less than 1,000 KWh are growing a bit faster because smaller consumers, which include residential and small commercial consumers, are also becoming aware of and taking up renewables. Thus, it is market growth driven by the combined support of income generation, corporate sustainability practices, and a change towards cleaner sources of energy.
Regional Analysis
In the recent past, the countries in Asia-Pacific have significantly started increasing the generation of renewable energy with the most focus on solar and wind energy. To facilitate the transition, they have set up several mechanisms and incentives like feed-in tariffs, RECs (renewable energy certificate) programs, and Renewable Energy targets. Key developments responsible for REC market growth in the region are China, Japan, and Australia. As an International Renewable Energy Certificate (I-REC), the market is booming across the region as a global framework for certification of production and usage of renewable equipment.
Key Players
Some of the major players in the Renewable Energy Certificate (REC) Market are 3Degrees, Inc. (US), Ecohz (Norway), Statkraft (Norway), Shell Energy (UK), EDF Trading Limited (UK), ENGIE (France), Enel Spa (Italy), STX Group (Netherlands). The major strategies adopted by these players include acquisitions, sales contracts, product launches, agreements, alliances, partnerships, and expansions.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=15096856
3Degrees, Inc.
3Degrees, Inc. is a globally recognized climate solutions provider and Certified B Corporation. The company specializes in renewable energy and decarbonization, helping organizations worldwide transition to a low-carbon economy. 3Degrees Inc. offers a comprehensive portfolio of Renewable Energy Certificates (RECs), enabling businesses to offset their electricity consumption with renewable energy sources. These RECs are sourced from diverse renewable projects, including wind, solar, and biomass, allowing clients to support sustainable energy initiatives while reducing their carbon footprint. The company also tailors REC portfolios to align with each client's specific sustainability objectives. Apart from RECs, 3Degrees provides Carbon Credits, Renewable Thermal Certificates (RTCs), and Clean Fuel Standard Services
Enel Spa
Enel Spa is a multinational energy company based in Italy, operating in over 30 countries. It is one of the global leading integrated electricity and gas operators, focusing on the generation, distribution, and sale of electricity and gas. The company offers REC through its subsidiaries Enel Green Power S.p.A. and Enel Global Trading S.p.A. The company operate in both compliance and voluntary REC markets, assisting clients in meeting renewable energy mandates or achieving sustainability goals. The company has a global presence with major operations in Europe, North America, and Asia Pacific.
Statkraft
Statkraft is a Norwegian state-owned enterprise and one of Europe's largest largest renewable energy producers and a global company in energy market operations. The company has evolved into a global leader in hydropower, wind power, solar energy, and other renewable sources. It is expanding globally to increase renewable power generation from water, wind and sun. Statkraft offers Renewable Energy Certificates (RECs), which are market-based instruments that certify the bearer owns one megawatt-hour (MWh) of electricity generated from a renewable energy resource. These certificates play a crucial role in promoting renewable energy by providing a mechanism for trading and tracking green energy production. The company conducts its business operations majorly in Europe, South America and Asia.
For more information, Inquire Now!
Related Reports:
Carbon Offset/Carbon Credit Market
Carbon Credit Validation Verification and Certification Market
Get access to the latest updates on Renewable Energy Certificate (REC) Companies and Renewable Energy Certificate (REC) Industry
About MarketsandMarkets™:
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
In addition, MarketsandMarkets SalesIQ enables sales teams to identify high-priority accounts and uncover hidden opportunities, helping them build more pipeline and win more deals with precision.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.
Contact:Mr. Rohan SalgarkarMarketsandMarkets™ INC.1615 South Congress Ave.Suite 103, Delray Beach, FL 33445USA: +1-888-600-6441Email: sales@marketsandmarkets.comVisit Our Website: https://www.marketsandmarkets.com/
Logo: https://mma.prnewswire.com/media/1868219/MarketsandMarkets_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/renewable-energy-certificate-rec-market-worth-45-45-billion-by-2030--marketsandmarkets-302416686.html
SOURCE MarketsandMarkets
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
4 hours ago
- Yahoo
Cleveland-Cliffs (CLF) Reports Q2 2025 Sales Decline to US$4934 Million
Cleveland-Cliffs recently faced challenges as their second-quarter 2025 earnings revealed sales declined to USD 4,934 million, while registering a net loss of USD 483 million compared to a modest net income last year. Despite these disappointing financial results, Cleveland-Cliffs's share price rose by 15% over the past month. This performance unfolded against the backdrop of a broader market that saw similar gains in July, although markets experienced a downturn due to economic concerns fueled by weak U.S. jobs data and renewed tariff policies. The company's operational struggles might have tempered the overall positive market momentum. We've identified 3 risks with Cleveland-Cliffs (at least 1 which is a bit unpleasant) and understanding the impact should be part of your investment process. Find companies with promising cash flow potential yet trading below their fair value. The recent earnings report highlighting Cleveland-Cliffs' net loss of US$483 million amidst sales of US$4.93 billion presents a challenging landscape for the company. Despite this, shares have climbed 15% in the past month, reflecting broader market trends, though these gains might be vulnerable to ongoing economic uncertainties, such as the U.S. jobs data concerns. Addressing this financial strain is crucial as Cleveland-Cliffs navigates its reliance on U.S. steel tariffs and OEM reshoring, central to its growth narrative. Over a longer five-year period, Cleveland-Cliffs' total shareholder return, encompassing both share price appreciation and dividends, marked an impressive increase of 83.58%. This growth sharply contrasts with the company's recent underperformance against the US Metals and Mining industry over the past year. The industry saw returns of 13.4%, surpassing Cleveland-Cliffs' performance during the same one-year period. Future revenue and earnings projections are aligned with anticipated benefits from reshoring and tariff protections, yet the magnitude of the recent loss highlights potential vulnerabilities. Analysts anticipate the revenue will rise, with margins eventually reaching profitability. However, any shifts in trade policies or market conditions could alter these forecasts. With the current share price at US$10.06, close to the target of US$10.99, the upward movement suggests market confidence, yet analysts see limited upside relative to the target, indicating cautious optimism about hitting expected milestones. According our valuation report, there's an indication that Cleveland-Cliffs' share price might be on the cheaper side. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include CLF. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
4 hours ago
- Yahoo
Recursion Pharmaceuticals (RXRX) Price Surges 9% Over Past Month
Recursion Pharmaceuticals experienced a price increase of 9% over the past month, positioning it against the backdrop of a broader market decline driven by geopolitical tensions and weak jobs data. Despite these broader market headwinds, which saw significant tech stock declines due to tariff concerns and disappointing economic indicators, Recursion managed to outperform. The company's stock movement appeared isolated from these wider trends, which implies internal factors or developments might have played a part, although specific catalysts weren't highlighted during this period. This performance is noteworthy given the current market's overall downward trend of 2.7%. We've identified 3 possible red flags for Recursion Pharmaceuticals (1 is potentially serious) that you should be aware of. AI is about to change healthcare. These 26 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early. Recursion Pharmaceuticals' recent 9% monthly share price increase amidst broader market declines may suggest that internal developments, rather than external factors, are influencing investor sentiment. Over the past year, however, the company's total shareholder return was a decline of 19.09%, highlighting a contrast to the short-term positive movement. Comparatively, RXRX underperformed the US Biotechs industry, which saw an 8.4% decline over the same period, and also lagged behind the US market return of 17.7%. The heightened interest in the stock could be linked to enthusiasm around its AI-driven drug discovery programs, including REC-617 and REC-994 trials, which suggest potential future revenue growth. Yet, Recursion's lack of profitability and reliance on successful trial outcomes may introduce uncertainty into earnings forecasts. The company's expected revenue growth of 39.9% annually for the next three years could be influenced by the new developments and partnerships, possibly providing support to the optimistic forecasts. The current share price of US$5.68 remains below the consensus analyst price target of US$7.14, indicating a potential upside of 25.7%. This price target reflects expectations of significant future revenue and earnings improvements. However, analysts' forecasts include assumptions such as increased profit margins and successful translation of ongoing projects into commercial revenues, underscoring the importance of navigating the risks and uncertainties outlined in their analysis. Investors may need to weigh these factors carefully when considering the company's ability to meet future targets. Evaluate Recursion Pharmaceuticals' prospects by accessing our earnings growth report. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include RXRX. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Sign in to access your portfolio
Yahoo
7 hours ago
- Yahoo
BNB Slides as Tariffs, Stronger Dollar and Fed Policy Weigh on Crypto Markets
BNB fell more than 4.5% in the last 24 hours, dropping from around $805.7 to $766 at the time of writing as investors move away from risk assets as U.S. interest-rate cut hopes faded. The selling accelerated near $803, where a surge in trading volume, roughly 56% above average, marked a turning point, according to CoinDesk Research's technical analysis model. BNB sank sharply from there, slicing through short-term support zones near $789 and $777. Overnight, the $767 level emerged as a key battleground, absorbing heavy sell orders and stalling the decline. Despite a small bounce toward $769, buying momentum faded quickly. The drop comes as President Donald Trump's tariffs start to take effect, with some kicking in today and others on Aug. 7. These tariffs saw the U.S. dollar index rise above 100 for the first time since May. Adding to the stronger dollar, interest rates may remain higher for longer. The Federal Reserve's preferred inflation measure, the core PCE, rose 2.8% year-over-year in June, damping hopes for a rate cut in September. The BNB slide mirrors the larger crypto landscape, with the CoinDesk 20 (CD20) index dropping 5.8% in the past 24 hours. The cryptocurrency is nevertheless seeing growing corporate adoption. CEA Industries (VAPE), backed by Binance co-founder Changpeng Zhao's family office, Yzi Labs, announced plans to raise up to $1.2 billion to build what it called the largest U.S.-listed BNB treasury. They aren't alone. Liminatus Pharma (LIMN), a clinical-stage biopharma firm, launched a BNB investment arm with a $500 million funding goal. Windtree Therapeutics (WINT) disclosed a $700 million BNB acquisition strategy, while Nano Labs reported buying 128,000 BNB as part of its new crypto treasury plan. Disclaimer: Parts of this article were generated with the assistance from AI tools and reviewed by our editorial team to ensure accuracy and adherence to our standards. For more information, see CoinDesk's full AI Policy.
